mariPOC

mariPOC is a multianalyte respiratory infection rapid test for point-of-care diagnostic use.

Random-access plate readerThe analytes are:

  • Influenza A virus
  • Influenza B virus
  • RS-virus
  • Parainfluenza 1 virus
  • Parainfluenza 2 virus
  • Parainfluenza 3 virus
  • Metapneumovirus
  • Adenovirus
  • S. pneumoniae
  • Streptococcus Group A


Visible plateThe test procedure:

  1. take a nasal swab sample
  2. cut the swab in a test tube
  3. add 1 mL of RTI sample buffer
  4. vortex 10-15 sec
  5. type the patient information to the ArcDiagnoser software
  6. insert the sample tube in the analyzer
  7. start the measurement
  8. view or print automated results from 20 min and 2 h timepoints

This test system will be launched in the beginning of 2010.

The test system will be CE marked for IVD use.

picture5peruskuvat_slide4

More news topics

  • mariPOC IVD CE marked
    ArcDia announces that its mariPOC® test system intended for IVD use, has received CE marking in September 29th 2010. mariPOC® is an automated analyser for multianalyte rapid respiratory infection pathogen testing. The first customer deliveries in Finland started already in November. More information is available at www.maripoc.com.
  • Scientific Conference Attendance 2011
    In 2011 ArcDia will be attending the following scientific conferences as an exhibitor: ESCV (European Society for Clinical Virology) Winter Meeting in London, United Kingdom, January 13-15th, 2011 Labquality Days & Exhibition 2011 in Helsinki, Finland, February 10-11, 2011 Infektiosairauksien ja kliinisen mikrobiologian alueellinen koulutuspäivä in Helsinki, Finland, April 12th, 2011 100 th Anniversary NVvM & Scientific Spring [...]
  • CE declaration of mariPOC analyser
    On April 2010 ArcDia declared a CE marking of the mariPOC® analyser, also known as ArcDia™ AD7 Plate Reader with dispensing unit, according to EMC and Low Voltage Directives. ArcDia™ AD7 Plate Reader serie represents the newest microfluorometer generation by ArcDia. For more information about the products please contact ArcDia International Oy Ltd.
  • Influenza A virus test IVD CE marked
    ArcDia™ Influenza A virus test has been IVD CE marked on March 17th. This is the continuation for the development work ArcDia reported on August 12th: “High-throughput screening test for pandemic swine influenza virus A(H1N1)v”. The ArcDia™ Influenza A virus test detects the pandemic influenza within 2 hours and with 10 times better sensitivity compared to [...]
  • Scientific Conference Attendance